SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Pete Wehrly, CEO of VIVEX Biologics, discusses the Company and its diverse portfolio in orthopedics and ...
In an interview with SmartTRAK, Parachute Health CEO David Gelbard discusses the Company and its novel, ...
It's time to get out there again and reconnect. SmartTRAK is excited to be attending SAWC Fall, the Symp...
We are pleased to announce that Gary Delhougne has joined the team at SmartTRAK as General Manager, Woun...
A big boost in Q2 with double-digit gains in all segments. The prevention of Hospital-Acquired Infection...
Advanced Wound Care saw a strong recovery against a weak comparator. For Q221, according to SmartTRAK Fi...
Changing market dynamics over the past ten years has not held back the robust Skin Substitute/CTP market...
A return to positive growth for the quarter, but gains lag behind pre-COVID-19 levels. The prevention of...
Advanced Wound Care begins to stabilize as in-person visits increase and elective procedures rebound. Fo...
Procedures using surgical matrices continued their recovery, with breast matrices benefiting more from c...
Login